JMP Securities Downgrades Uroplasty (UPI) to Market Perform
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
JMP Securities downgraded Uroplasty (NASDAQ: UPI) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $3.10 yesterday.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $3.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Double Downgrades AU Optronics (2409:TT) (AUO) to Underweight
- Morgan Stanley Downgrades Innolux Corp. (3481:TT) to Equalweight
- JPMorgan Downgrades Pilbara Minerals Ltd (PLS:AU) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
